Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading ARNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.87%73.360.9%$725.27m
AMGNAmgen Inc.
0.66%180.371.1%$594.92m
CELGCelgene Corporation
1.20%136.621.1%$588.74m
REGNRegeneron Pharmaceuticals, Inc.
2.53%519.602.7%$543.76m
BIIBBiogen Inc.
0.65%283.781.2%$408.07m
VRTXVertex Pharmaceuticals Incorporated
-0.21%159.361.9%$369.36m
ALXNAlexion Pharmaceuticals, Inc.
1.68%129.441.9%$285.29m
CLVSClovis Oncology, Inc.
3.69%86.9418.0%$175.33m
TSROTESARO, Inc.
3.44%128.2814.7%$169.88m
INCYIncyte Corporation
1.52%132.432.6%$169.02m
ILMNIllumina, Inc.
-0.43%173.133.5%$159.15m
EXELExelixis, Inc.
2.13%27.326.5%$156.62m
BMRNBioMarin Pharmaceutical Inc.
0.38%87.564.4%$131.55m
KITEKite Pharma, Inc.
1.78%107.3116.1%$121.77m
BLUEBluebird Bio, Inc.
0.10%97.4019.3%$117.43m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.